Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

TETRAHYDROZOLINE HYDRO

Active
SPE2DP-26-T-4750Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract, identified as SPE2DP-26-T-4750, is for the procurement of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP, in 15 ml bottles. The order specifies a quantity of 6 bottles with a delivery requirement of 20 days after the order is placed. The item is regulated by the FDA and must adhere to a non-extendable shelf life of 36 months. Packaging must follow commercial standards and be marked according to Medical Marking Standard No. 1. The contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. Delivery is set as FOB Destination, with inspection and acceptance also occurring at the destination. The procurement is managed by the Department of Defense Medical Supply Chain Pharmacy FSA for performance at Fort Bragg.

General Info

Procure 6 bottles of Tetrahydrozoline Hydrochloride for Fort Bragg within 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4750.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
TETRAHYDROZOLINE HYDROCHLORIDE OPHTHALMI
TETRAHYDROZOLINE HCL OPHTHALMIC SOLUTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
0.05 PERCENT, 15 ML
PFIZER NDC74300-0008-03
MAJOR NDC 00904-6334-35
AAC "L"; U/I "BT" 15 ML
1 BT = 15 ML
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
SPE2DP-26-T-4750
SECTION B
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION
OF THE MEDICAL MARKING STANDARD NO. 1
https://www.dla.mil/Logistics-Operations/Packaging/
DMS PHARMACEUTICAL GROUP INC 1UNB0 P/N NDC50804-0141-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018013172 0001 BT 6.000
NSN/MATERIAL:6505001394600
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-139-4600 Quantity: 6 BT Purchase Request: 7018013172QTY: 6 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
PHARM MANUF/DISTR DIV - FSA
Solicitation # SPE2D2-26-R-0012
The Defense Logistics Agency is preparing to solicit a national requirements contract for Febuxostat Tablets in 40 MG and 80 MG strengths, packaged in 30-count bottles, under solicitation number SPE2D2-26-R-0012. This is an unrestricted, fully competitive acquisition classified as a commercial item under FAR Part 12, with a firm-fixed price structure and a one-year base period plus four one-year options. The contract will serve as the sole national supply source for the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service, supplying these entities through DLA and VA prime vendor programs. Annual usage estimates will be detailed in the solicitation’s Schedule of Supplies, and the contract will be governed by FAR 52.216-21 (Requirements). The NAICS code for this procurement is 325412, and it is managed by DLA Troop Support out of Philadelphia, Pennsylvania. The solicitation is set to be posted on DIBBS and SAM.gov, with a projected release date in June 2026, though DLA retains the right to issue it earlier or later. Interested vendors are encouraged to monitor these platforms and set up automated notifications for any updates. Questions or comments may be directed to Christopher Newman at Christopher.Newman@dla.mil or (445) 737-7371, with Jason C. Wray listed as a secondary point of contact. All responsible sources may submit proposals, and the contract will be awarded based on competitive evaluation without set-asides, ensuring broad market access.
Defense Logistics Agency

POSTED

about 9 hours ago

DEADLINE

in 30 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency